91制片厂

Published on Market Research Reports庐 Inc. ()

Home > Global Dutasteride Market Research Report 2023

Global Dutasteride Market Research Report 2023

Publication ID: 
PB510233860
Publication Date: 
October 9, 2023
Pages: 
97
Publisher: 
MRRPB5
Countries: 
Global [1]
USD 2,900.00

Please choose the suitable license type from above. More details are given under tab "Report License Types" below.

Pharma & Healthcare [2]
Healthcare [3]
Description: 

Dutasteride, sold under the brand name Avodart among others, is a medication used primarily to treat enlarged prostate in men.

The global Dutasteride market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Dutasteride 91制片厂.

Key manufacturers engaged in the Dutasteride industry include GSK, Bionpharma, Rising Pharmaceuticals, Teva, Mylan, Zydus, Amneal Pharma, Apotex and Marksans Pharma, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.

When refers to consumption region, % volume of Dutasteride were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Dutasteride market and estimated to attract more attentions from industry insiders and investors.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Dutasteride market with multiple angles, which provides sufficient supports to readers鈥� strategy and decision making.

By Company

  1. GSK
  2. Bionpharma
  3. Rising Pharmaceuticals
  4. Teva
  5. Mylan
  6. Zydus
  7. Amneal Pharma
  8. Apotex
  9. Marksans Pharma
  10. Breckenridge Pharmaceutical

Segment by Type

  • Type I
  • Type II

Segment by Application

  • Hospital
  • Drug Store

Consumption by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Taiwan
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE

The Dutasteride report covers below items:

  • Chapter 1: Product Basic Information (Definition, Type and Application)
  • Chapter 2: Manufacturers鈥� Competition Patterns
  • Chapter 3: Country Level Sales Analysis
  • Chapter 4: Product Type Analysis
  • Chapter 5: Product Application Analysis
  • Chapter 6: Manufacturers鈥� Outline
  • Chapter 7: Industry Chain, Market Channel and Customer Analysis
  • Chapter 8: Market Opportunities and Challenges
  • Chapter 9: Market Conclusions
  • Chapter 10: Research Methodology and Data Source

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents: 

1 Dutasteride Market Overview
1.1 Product Overview and Scope of Dutasteride
1.2 Dutasteride Segment by Type
1.2.1 Global Dutasteride Market Value Comparison by Type (2023-2029)
1.2.2 Type I
1.2.3 Type II
1.3 Dutasteride Segment by Application
1.3.1 Global Dutasteride Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Dutasteride Market Size Estimates and Forecasts
1.4.1 Global Dutasteride Revenue 2018-2029
1.4.2 Global Dutasteride Sales 2018-2029
1.4.3 Global Dutasteride Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Dutasteride Market Competition by Manufacturers
2.1 Global Dutasteride Sales Market Share by Manufacturers (2018-2023)
2.2 Global Dutasteride Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Dutasteride Average Price by Manufacturers (2018-2023)
2.4 Global Dutasteride Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Dutasteride, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Dutasteride, Product Type & Application
2.7 Dutasteride Market Competitive Situation and Trends
2.7.1 Dutasteride Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Dutasteride Players Market Share by Revenue
2.7.3 Global Dutasteride Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dutasteride Retrospective Market Scenario by Region
3.1 Global Dutasteride Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Dutasteride Global Dutasteride Sales by Region: 2018-2029
3.2.1 Global Dutasteride Sales by Region: 2018-2023
3.2.2 Global Dutasteride Sales by Region: 2024-2029
3.3 Global Dutasteride Global Dutasteride Revenue by Region: 2018-2029
3.3.1 Global Dutasteride Revenue by Region: 2018-2023
3.3.2 Global Dutasteride Revenue by Region: 2024-2029
3.4 North America Dutasteride Market Facts & Figures by Country
3.4.1 North America Dutasteride Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Dutasteride Sales by Country (2018-2029)
3.4.3 North America Dutasteride Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Dutasteride Market Facts & Figures by Country
3.5.1 Europe Dutasteride Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Dutasteride Sales by Country (2018-2029)
3.5.3 Europe Dutasteride Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Dutasteride Market Facts & Figures by Country
3.6.1 Asia Pacific Dutasteride Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Dutasteride Sales by Country (2018-2029)
3.6.3 Asia Pacific Dutasteride Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Dutasteride Market Facts & Figures by Country
3.7.1 Latin America Dutasteride Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Dutasteride Sales by Country (2018-2029)
3.7.3 Latin America Dutasteride Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Dutasteride Market Facts & Figures by Country
3.8.1 Middle East and Africa Dutasteride Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Dutasteride Sales by Country (2018-2029)
3.8.3 Middle East and Africa Dutasteride Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Dutasteride Sales by Type (2018-2029)
4.1.1 Global Dutasteride Sales by Type (2018-2023)
4.1.2 Global Dutasteride Sales by Type (2024-2029)
4.1.3 Global Dutasteride Sales Market Share by Type (2018-2029)
4.2 Global Dutasteride Revenue by Type (2018-2029)
4.2.1 Global Dutasteride Revenue by Type (2018-2023)
4.2.2 Global Dutasteride Revenue by Type (2024-2029)
4.2.3 Global Dutasteride Revenue Market Share by Type (2018-2029)
4.3 Global Dutasteride Price by Type (2018-2029)
5 Segment by Application
5.1 Global Dutasteride Sales by Application (2018-2029)
5.1.1 Global Dutasteride Sales by Application (2018-2023)
5.1.2 Global Dutasteride Sales by Application (2024-2029)
5.1.3 Global Dutasteride Sales Market Share by Application (2018-2029)
5.2 Global Dutasteride Revenue by Application (2018-2029)
5.2.1 Global Dutasteride Revenue by Application (2018-2023)
5.2.2 Global Dutasteride Revenue by Application (2024-2029)
5.2.3 Global Dutasteride Revenue Market Share by Application (2018-2029)
5.3 Global Dutasteride Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Dutasteride Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GSK Dutasteride Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 Bionpharma
6.2.1 Bionpharma Corporation Information
6.2.2 Bionpharma Description and Business Overview
6.2.3 Bionpharma Dutasteride Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Bionpharma Dutasteride Product Portfolio
6.2.5 Bionpharma Recent Developments/Updates
6.3 Rising Pharmaceuticals
6.3.1 Rising Pharmaceuticals Corporation Information
6.3.2 Rising Pharmaceuticals Description and Business Overview
6.3.3 Rising Pharmaceuticals Dutasteride Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Rising Pharmaceuticals Dutasteride Product Portfolio
6.3.5 Rising Pharmaceuticals Recent Developments/Updates
6.4 Teva
6.4.1 Teva Corporation Information
6.4.2 Teva Description and Business Overview
6.4.3 Teva Dutasteride Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Teva Dutasteride Product Portfolio
6.4.5 Teva Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Dutasteride Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Mylan Dutasteride Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Zydus
6.6.1 Zydus Corporation Information
6.6.2 Zydus Description and Business Overview
6.6.3 Zydus Dutasteride Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Zydus Dutasteride Product Portfolio
6.6.5 Zydus Recent Developments/Updates
6.7 Amneal Pharma
6.6.1 Amneal Pharma Corporation Information
6.6.2 Amneal Pharma Description and Business Overview
6.6.3 Amneal Pharma Dutasteride Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Amneal Pharma Dutasteride Product Portfolio
6.7.5 Amneal Pharma Recent Developments/Updates
6.8 Apotex
6.8.1 Apotex Corporation Information
6.8.2 Apotex Description and Business Overview
6.8.3 Apotex Dutasteride Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Apotex Dutasteride Product Portfolio
6.8.5 Apotex Recent Developments/Updates
6.9 Marksans Pharma
6.9.1 Marksans Pharma Corporation Information
6.9.2 Marksans Pharma Description and Business Overview
6.9.3 Marksans Pharma Dutasteride Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Marksans Pharma Dutasteride Product Portfolio
6.9.5 Marksans Pharma Recent Developments/Updates
6.10 Breckenridge Pharmaceutical
6.10.1 Breckenridge Pharmaceutical Corporation Information
6.10.2 Breckenridge Pharmaceutical Description and Business Overview
6.10.3 Breckenridge Pharmaceutical Dutasteride Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Breckenridge Pharmaceutical Dutasteride Product Portfolio
6.10.5 Breckenridge Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Dutasteride Industry Chain Analysis
7.2 Dutasteride Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Dutasteride Production Mode & Process
7.4 Dutasteride Sales and Marketing
7.4.1 Dutasteride Sales Channels
7.4.2 Dutasteride Distributors
7.5 Dutasteride Customers
8 Dutasteride Market Dynamics
8.1 Dutasteride Industry Trends
8.2 Dutasteride Market Drivers
8.3 Dutasteride Market Challenges
8.4 Dutasteride Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned: 
  1. GSK
  2. Bionpharma
  3. Rising Pharmaceuticals
  4. Teva
  5. Mylan
  6. Zydus
  7. Amneal Pharma
  8. Apotex
  9. Marksans Pharma
  10. Breckenridge Pharmaceutical
License Types: 

Single User License (PDF)

  • This license allows for use of a publication by one person.
  • This person may print out a single copy of the publication.
  • This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • This person cannot share the publication (or any information contained therein) with any other person or persons.
  • Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

  • This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
  • These users may print out a single copy of the publication.
  • These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
  • These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
  • Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
  • Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

  • This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
  • Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
  • These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

Source URL:/mrrpb5/global-dutasteride-market-research-report-2023

Links
[1] /countries/global[2] /pharma-healthcare[3] /healthcare